MedPath

The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers

Not Applicable
Completed
Conditions
Prediabetes
Interventions
Other: Oral glucose tolerance
Registration Number
NCT02229487
Lead Sponsor
Ramathibodi Hospital
Brief Summary

Hypothesis

1. Prediabetes patients who have insufficient sleep will have worse glucose tolerance than those with normal sleep duration.

2. Prediabetes patients with short sleep will have a delayed or reduced GLP-1 response to a standardized meal

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  1. Patients with prediabetes (HbA1c 5.7-6.4% or history of fasting plasma glucose 100-125 mg/dl) who receive medical care at Ramathibodi Hospital
  2. Age 18 or older
  3. Can understand Thai (speaking, listening and reading)
  4. Agree to participate by written informed consent
Exclusion Criteria
  1. Those who depend on others for feeding (such as stroke patients)
  2. Shift workers
  3. History of congestive heart failure or low ejection fraction
  4. Chronic obstructive pulmonary disease, end stage renal disease or chronic liver disease (AST or ALT > 3 times the upper limit of normal)
  5. Use of medications: opioids/ narcotics , alpha blockers (prazosin, doxazosin, terazosin), clonidine, methyldopa, nitroglycerin
  6. Patients with permanent pacemaker
  7. History of previous stroke

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Normal SleepersOral glucose tolerancePrediabetes patients with normal sleep duration (7-8 hours/ night) as measured objectively
Short SleepersOral glucose tolerancePrediabetes patients with short sleep duration (\<6 hours/night) as measured objectively
Primary Outcome Measures
NameTimeMethod
GLP-1 Levels in Response to Oral Glucose Tolerance Test2 weeks

Prediabetes patients with and without short sleep will undergo an oral glucose tolerance test with measurement of GLP-1 levels

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine Ramathibodi Hospital

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath